Enhancement of the antimicrobial properties of bacteriophage-K via stabilisation using oil-in-water nano-emulsions

Patricia Pérez Esteban, Diana Alves, Mark C. Enright, Jessica E. Bean, Alison Gaudion, A. T. A. Jenkins, Amber E. R. Young, Tom C. Arnot

Research output: Contribution to journalArticle

21 Citations (Scopus)
76 Downloads (Pure)

Abstract

Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalised patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This paper evaluates the anti-microbial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilised and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K. Bacteriophage infectivity, and the influence of storage time of the preparation, were assessed by turbidity measurements of bacterial samples. Newly prepared Bacteriophage K / nano-emulsion formulations have greater anti-microbial activity than freely suspended bacteriophage. The phage loaded emulsions caused rapid and complete bacterial death of three different strains of Staphylococcus aureus. The same effect was observed for preparations that were either stored at room temperature (18 - 20°C), or chilled at 4°C, for up to 10 days of storage. A response surface design of experiments was used to gain insight on the relative effects of the emulsion formulation on bacterial growth and phage lytic activity. More diluted emulsions had a less significant effect on bacterial growth, and diluted bacteriophage-emulsion preparations yielded greater antibacterial activity. The enhancement of bacteriophage activity when delivered via nano-emulsions has yet to be reported. This prompts further investigation into the use of these formulations for the development of novel anti-microbial wound management strategies.
Original languageEnglish
Pages (from-to)932-944
Number of pages13
JournalBiotechnology Progress
Volume30
Issue number4
Early online date14 Apr 2014
DOIs
Publication statusPublished - 31 Aug 2014

Fingerprint

Emulsions
Bacteriophages
Oils
Water
Staphylococcus aureus
Growth
Conservation of Natural Resources
Wounds and Injuries
Bandages
Hot Temperature
Anti-Bacterial Agents
Viruses
Bacteria
Temperature

Keywords

  • S. aureus infections
  • Phage therapy
  • oil-in-water nano-emulsion;burn wound related infections;responsive wound dressings

Cite this

Enhancement of the antimicrobial properties of bacteriophage-K via stabilisation using oil-in-water nano-emulsions. / Pérez Esteban, Patricia; Alves, Diana; Enright, Mark C.; Bean, Jessica E.; Gaudion, Alison; Jenkins, A. T. A.; Young, Amber E. R.; Arnot, Tom C.

In: Biotechnology Progress, Vol. 30, No. 4, 31.08.2014, p. 932-944.

Research output: Contribution to journalArticle

Pérez Esteban, Patricia ; Alves, Diana ; Enright, Mark C. ; Bean, Jessica E. ; Gaudion, Alison ; Jenkins, A. T. A. ; Young, Amber E. R. ; Arnot, Tom C. / Enhancement of the antimicrobial properties of bacteriophage-K via stabilisation using oil-in-water nano-emulsions. In: Biotechnology Progress. 2014 ; Vol. 30, No. 4. pp. 932-944.
@article{56c5ffe1921f47078a332279d4e62740,
title = "Enhancement of the antimicrobial properties of bacteriophage-K via stabilisation using oil-in-water nano-emulsions",
abstract = "Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalised patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This paper evaluates the anti-microbial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilised and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K. Bacteriophage infectivity, and the influence of storage time of the preparation, were assessed by turbidity measurements of bacterial samples. Newly prepared Bacteriophage K / nano-emulsion formulations have greater anti-microbial activity than freely suspended bacteriophage. The phage loaded emulsions caused rapid and complete bacterial death of three different strains of Staphylococcus aureus. The same effect was observed for preparations that were either stored at room temperature (18 - 20°C), or chilled at 4°C, for up to 10 days of storage. A response surface design of experiments was used to gain insight on the relative effects of the emulsion formulation on bacterial growth and phage lytic activity. More diluted emulsions had a less significant effect on bacterial growth, and diluted bacteriophage-emulsion preparations yielded greater antibacterial activity. The enhancement of bacteriophage activity when delivered via nano-emulsions has yet to be reported. This prompts further investigation into the use of these formulations for the development of novel anti-microbial wound management strategies.",
keywords = "S. aureus infections, Phage therapy, oil-in-water nano-emulsion;burn wound related infections;responsive wound dressings",
author = "{P{\'e}rez Esteban}, Patricia and Diana Alves and Enright, {Mark C.} and Bean, {Jessica E.} and Alison Gaudion and Jenkins, {A. T. A.} and Young, {Amber E. R.} and Arnot, {Tom C.}",
year = "2014",
month = "8",
day = "31",
doi = "10.1002/btpr.1898",
language = "English",
volume = "30",
pages = "932--944",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Enhancement of the antimicrobial properties of bacteriophage-K via stabilisation using oil-in-water nano-emulsions

AU - Pérez Esteban, Patricia

AU - Alves, Diana

AU - Enright, Mark C.

AU - Bean, Jessica E.

AU - Gaudion, Alison

AU - Jenkins, A. T. A.

AU - Young, Amber E. R.

AU - Arnot, Tom C.

PY - 2014/8/31

Y1 - 2014/8/31

N2 - Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalised patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This paper evaluates the anti-microbial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilised and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K. Bacteriophage infectivity, and the influence of storage time of the preparation, were assessed by turbidity measurements of bacterial samples. Newly prepared Bacteriophage K / nano-emulsion formulations have greater anti-microbial activity than freely suspended bacteriophage. The phage loaded emulsions caused rapid and complete bacterial death of three different strains of Staphylococcus aureus. The same effect was observed for preparations that were either stored at room temperature (18 - 20°C), or chilled at 4°C, for up to 10 days of storage. A response surface design of experiments was used to gain insight on the relative effects of the emulsion formulation on bacterial growth and phage lytic activity. More diluted emulsions had a less significant effect on bacterial growth, and diluted bacteriophage-emulsion preparations yielded greater antibacterial activity. The enhancement of bacteriophage activity when delivered via nano-emulsions has yet to be reported. This prompts further investigation into the use of these formulations for the development of novel anti-microbial wound management strategies.

AB - Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalised patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This paper evaluates the anti-microbial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilised and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K. Bacteriophage infectivity, and the influence of storage time of the preparation, were assessed by turbidity measurements of bacterial samples. Newly prepared Bacteriophage K / nano-emulsion formulations have greater anti-microbial activity than freely suspended bacteriophage. The phage loaded emulsions caused rapid and complete bacterial death of three different strains of Staphylococcus aureus. The same effect was observed for preparations that were either stored at room temperature (18 - 20°C), or chilled at 4°C, for up to 10 days of storage. A response surface design of experiments was used to gain insight on the relative effects of the emulsion formulation on bacterial growth and phage lytic activity. More diluted emulsions had a less significant effect on bacterial growth, and diluted bacteriophage-emulsion preparations yielded greater antibacterial activity. The enhancement of bacteriophage activity when delivered via nano-emulsions has yet to be reported. This prompts further investigation into the use of these formulations for the development of novel anti-microbial wound management strategies.

KW - S. aureus infections

KW - Phage therapy

KW - oil-in-water nano-emulsion;burn wound related infections;responsive wound dressings

U2 - 10.1002/btpr.1898

DO - 10.1002/btpr.1898

M3 - Article

VL - 30

SP - 932

EP - 944

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 4

ER -